0.09
-0.0047(-5.22%)
Currency In USD
| Previous Close | 0.09 |
| Open | 0.08 |
| Day High | 0.09 |
| Day Low | 0.08 |
| 52-Week High | 2.57 |
| 52-Week Low | 0.08 |
| Volume | 13.81M |
| Average Volume | 8.63M |
| Market Cap | 9.5M |
| PE | -0.12 |
| EPS | -0.69 |
| Moving Average 50 Days | 0.31 |
| Moving Average 200 Days | 0.69 |
| Change | -0 |
If you invested $1000 in Eyenovia, Inc. (EYEN) since IPO date, it would be worth $8.6 as of December 22, 2024 at a share price of $0.085. Whereas If you bought $1000 worth of Eyenovia, Inc. (EYEN) shares 5 years ago, it would be worth $22.75 as of December 22, 2024 at a share price of $0.085.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
GlobeNewswire Inc.
Dec 06, 2024 1:00 PM GMT
NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medica
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering
GlobeNewswire Inc.
Nov 25, 2024 1:00 PM GMT
NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medicat
Eyenovia Provides Update on Restructuring Efforts
GlobeNewswire Inc.
Nov 22, 2024 12:00 PM GMT
Avenue Capital agrees to Company’s deferral of principal and interest payments on its outstanding debt until the end of February 2025 Eyenovia continues to evaluate a broad range of strategic alternatives to maximize stakeholder value NEW YORK, Nov.